DFX Intelligence
Venture Capital Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.
Companies / C••••••••
C••••••••
C•••••••• Biopharma is a clinical-stage biotech company developing next-generation precision medicines for immunology and autoimmune disease. Our pipeline targets SIK3 to deliver transformative therapies where unmet need remains high.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 0
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 2
Financing history
0 rounds
No dated round yet.
Investors on record
2 edges
- L••••••• M••••••••• L•• portfolio listing Fact longwoodfund.com
- S•••••••• I••••••••• I••• portfolio listing Fact sofinnova.com
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
- Sep 16, 2026C•••••••• no longer listed on S•••••••• I••••••••• I•••'s portfolio pageRemoved from portfolio page Inference Venture organization websites (about, team, portfolio, thesis, news pages)
Evidence
5 observations
Every observation on this company
- Description: C•••••••• Biopharma is a clinical-stage biotech company developing next-generation precision medicines for immunology and autoimmune disease. Our pipeline targets SIK3 to deliver transformative therapies where unmet need remains high. Sep 12, 2026 Fact Portfolio company websites (about, investors, press pages)
- Listed on portfolio page: S•••••••• I••••••••• I••• Sep 12, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: L••••••• M••••••••• L•• Sep 12, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Website status: ok Sep 12, 2026 Fact Portfolio company websites (about, investors, press pages)
- Site title: C•••••••• Biopharma | Advancing Tomorrow's Medicines Sep 12, 2026 Fact Portfolio company websites (about, investors, press pages)